Fingerprint
Dive into the research topics where Steven Paul is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Author Correction: Novel drug treatments for schizophrenia (Nature Reviews Drug Discovery, (2026), 10.1038/s41573-025-01335-w)
Coyle, J. T. & Paul, S. M., 2026, (Accepted/In press) In: Nature Reviews Drug Discovery.Research output: Contribution to journal › Comment/debate
Open Access -
Muscarinic Acetylcholine Receptor Activators as Transformative Therapeutics for Schizophrenia
Conn, P. J. & Paul, S. M., 2026, In: Annual review of medicine. 77, 1, p. 399-413 15 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Novel drug treatments for schizophrenia
Coyle, J. T. & Paul, S. M., Apr 2026, In: Nature Reviews Drug Discovery. 25, 4, p. 310-330 21 p.Research output: Contribution to journal › Review article › peer-review
3 Link opens in a new tab Scopus citations -
Targeting muscarinic receptors for treating schizophrenia
Paul, S. M. & Yohn, S. E., Jan 2026, In: Neurotherapeutics. 23, 1, e00839.Research output: Contribution to journal › Review article › peer-review
Open Access -
25-hydroxycholesterol promotes brain cytokine production and leukocyte infiltration in a mouse model of lipopolysaccharide-induced neuroinflammation
Romero, J., Toral-Rios, D., Yu, J., Paul, S. M. & Cashikar, A. G., Dec 2024, In: Journal of Neuroinflammation. 21, 1, 251.Research output: Contribution to journal › Article › peer-review
Open Access12 Link opens in a new tab Scopus citations